{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:46:53Z","timestamp":1785732413237,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Polyglutamine (polyQ) diseases comprise Huntington\u2019s disease and several subtypes of spinocerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3). The genomic expansion of coding <jats:italic>CAG<\/jats:italic> trinucleotide sequence in disease genes leads to the production and accumulation of misfolded polyQ domain-containing disease proteins, which cause cellular dysfunction and neuronal death. As one of the principal cellular protein clearance pathways, the activity of the ubiquitin\u2013proteasome system (UPS) is tightly regulated to ensure efficient clearance of damaged and toxic proteins. Emerging evidence demonstrates that UPS plays a crucial role in the pathogenesis of polyQ diseases. Ubiquitin (Ub) E3 ligases catalyze the transfer of a Ub tag to label proteins destined for proteasomal clearance. In this study, we identified an E3 ligase, pre-mRNA processing factor 19 (Prpf19\/prp19), that modulates expanded ataxin-3 (ATXN3-polyQ), disease protein of SCA3, induced neurodegeneration in both mammalian and <jats:italic>Drosophila<\/jats:italic> disease models. We further showed that Prpf19\/prp19 promotes poly-ubiquitination and degradation of mutant ATXN3-polyQ protein. Our data further demonstrated the nuclear localization of Prpf19\/prp19 is essential for eliciting its modulatory function towards toxic ATXN3-polyQ protein. Intriguingly, we found that exocyst complex component 7 (Exoc7\/exo70), a Prpf19\/prp19 interacting partner, modulates expanded ATXN3-polyQ protein levels and toxicity in an opposite manner to Prpf19\/prp19. Our data suggest that Exoc7\/exo70 exerts its ATXN3-polyQ-modifying effect through regulating the E3 ligase function of Prpf19\/prp19. In summary, this study allows us to better define the mechanistic role of Exoc7\/exo70-regulated Prpf19\/prp19-associated protein ubiquitination pathway in SCA3 pathogenesis.<\/jats:p>","DOI":"10.1038\/s41419-021-03444-x","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T09:11:03Z","timestamp":1612429863000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["A fine balance between Prpf19 and Exoc7 in achieving degradation of aggregated protein and suppression of cell death in spinocerebellar ataxia type 3"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9276-0378","authenticated-orcid":false,"given":"Zhefan Stephen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5490-1697","authenticated-orcid":false,"given":"Kevin","family":"Talbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4307-474X","authenticated-orcid":false,"given":"Ho Yin Edwin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,2]]},"reference":[{"key":"3444_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","volume":"14","author":"AP Lieberman","year":"2019","unstructured":"Lieberman, A. P., Shakkottai, V. G. & Albin, R. L. Polyglutamine repeats in neurodegenerative diseases. Annu Rev. Pathol. 14, 1\u201327 (2019).","journal-title":"Annu Rev. Pathol."},{"key":"3444_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/B978-0-444-63233-3.00011-7","volume":"147","author":"CA Stoyas","year":"2018","unstructured":"Stoyas, C. A. & La Spada, A. R. The CAG-polyglutamine repeat diseases: a clinical, molecular, genetic, and pathophysiologic nosology. Handb. Clin. Neurol. 147, 143\u2013170 (2018).","journal-title":"Handb. Clin. Neurol."},{"key":"3444_CR3","doi-asserted-by":"publisher","first-page":"104635","DOI":"10.1016\/j.nbd.2019.104635","volume":"134","author":"HS McLoughlin","year":"2020","unstructured":"McLoughlin, H. S., Moore, L. R. & Paulson, H. L. Pathogenesis of SCA3 and implications for other polyglutamine diseases. Neurobiol. Dis. 134, 104635 (2020).","journal-title":"Neurobiol. Dis."},{"key":"3444_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/bpa.12412","volume":"27","author":"K Seidel","year":"2017","unstructured":"Seidel, K. et al. On the distribution of intranuclear and cytoplasmic aggregates in the brainstem of patients with spinocerebellar ataxia type 2 and 3. Brain Pathol. 27, 345\u2013355 (2017).","journal-title":"Brain Pathol."},{"key":"3444_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/jnc.14541","volume":"148","author":"CA Matos","year":"2019","unstructured":"Matos, C. A., de Almeida, L. P. & Nobrega, C. Machado-Joseph disease\/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy. J. Neurochem. 148, 8\u201328 (2019).","journal-title":"J. Neurochem."},{"key":"3444_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.4103\/1673-5374.251193","volume":"14","author":"ZS Chen","year":"2019","unstructured":"Chen, Z. S. & Chan, H. Y. E. Transcriptional dysregulation in neurodegenerative diseases: who tipped the balance of Yin Yang 1 in the brain? Neural Regen. Res. 14, 1148\u20131151 (2019).","journal-title":"Neural Regen. Res."},{"key":"3444_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnmol.2018.00153","volume":"11","author":"C Xiang","year":"2018","unstructured":"Xiang, C., Zhang, S., Dong, X., Ma, S. & Cong, S. Transcriptional dysregulation and post-translational modifications in polyglutamine diseases: from pathogenesis to potential therapeutic strategies. Front Mol. Neurosci. 11, 153 (2018).","journal-title":"Front Mol. Neurosci."},{"key":"3444_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.nbd.2008.03.011","volume":"31","author":"AH Chou","year":"2008","unstructured":"Chou, A. H. et al. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol. Dis. 31, 89\u2013101 (2008).","journal-title":"Neurobiol. Dis."},{"key":"3444_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ana.10101","volume":"51","author":"T Schmidt","year":"2002","unstructured":"Schmidt, T. et al. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann. Neurol. 51, 302\u2013310 (2002).","journal-title":"Ann. Neurol."},{"key":"3444_CR10","doi-asserted-by":"publisher","first-page":"7648","DOI":"10.1074\/jbc.M706620200","volume":"283","author":"A Mishra","year":"2008","unstructured":"Mishra, A. et al. E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J. Biol. Chem. 283, 7648\u20137656 (2008).","journal-title":"J. Biol. Chem."},{"key":"3444_CR11","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1096\/fj.201700801RR","volume":"32","author":"H Yang","year":"2018","unstructured":"Yang, H. et al. PolyQ-expanded huntingtin and ataxin-3 sequester ubiquitin adaptors hHR23B and UBQLN2 into aggregates via conjugated ubiquitin. FASEB J. 32, 2923\u20132933 (2018).","journal-title":"FASEB J."},{"key":"3444_CR12","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.bbadis.2014.04.014","volume":"1842","author":"D Chhangani","year":"2014","unstructured":"Chhangani, D. et al. Mahogunin ring finger 1 suppresses misfolded polyglutamine aggregation and cytotoxicity. Biochim Biophys. Acta 1842, 1472\u20131484 (2014).","journal-title":"Biochim Biophys. Acta"},{"key":"3444_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature09299","volume":"467","author":"BH Lee","year":"2010","unstructured":"Lee, B. H. et al. Enhancement of proteasome activity by a small-molecule inhibitor of USP14. Nature 467, 179\u2013184 (2010).","journal-title":"Nature"},{"key":"3444_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2013.01.006","volume":"70","author":"HL Wang","year":"2013","unstructured":"Wang, H. L. et al. H1152 promotes the degradation of polyglutamine-expanded ataxin-3 or ataxin-7 independently of its ROCK-inhibiting effect and ameliorates mutant ataxin-3-induced neurodegeneration in the SCA3 transgenic mouse. Neuropharmacology 70, 1\u201311 (2013).","journal-title":"Neuropharmacology"},{"key":"3444_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-biochem-060815-014922","volume":"86","author":"N Zheng","year":"2017","unstructured":"Zheng, N. & Shabek, N. Ubiquitin ligases: structure, function, and regulation. Annu Rev. Biochem. 86, 129\u2013157 (2017).","journal-title":"Annu Rev. Biochem."},{"key":"3444_CR16","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrm.2016.91","volume":"17","author":"L Buetow","year":"2016","unstructured":"Buetow, L. & Huang, D. T. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 17, 626\u2013642 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"3444_CR17","doi-asserted-by":"publisher","first-page":"104697","DOI":"10.1016\/j.nbd.2019.104697","volume":"137","author":"NS Ashraf","year":"2020","unstructured":"Ashraf, N. S. et al. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the spinocerebellar ataxia type 3 disease protein. Neurobiol. Dis. 137, 104697 (2020).","journal-title":"Neurobiol. Dis."},{"key":"3444_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/jnc.14669","volume":"149","author":"ZS Chen","year":"2019","unstructured":"Chen, Z. S., Wong, A. K. Y., Cheng, T. C., Koon, A. C. & Chan, H. Y. E. FipoQ\/FBXO33, a cullin-1-based ubiquitin ligase complex component modulates ubiquitination and solubility of polyglutamine disease protein. J. Neurochem. 149, 781\u2013798 (2019).","journal-title":"J. Neurochem."},{"key":"3444_CR19","doi-asserted-by":"publisher","first-page":"6569","DOI":"10.1093\/emboj\/19.23.6569","volume":"19","author":"P Ajuh","year":"2000","unstructured":"Ajuh, P. et al. Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry. EMBO J. 19, 6569\u20136581 (2000).","journal-title":"EMBO J."},{"key":"3444_CR20","doi-asserted-by":"publisher","first-page":"33111","DOI":"10.1074\/jbc.M102755200","volume":"276","author":"S Hatakeyama","year":"2001","unstructured":"Hatakeyama, S., Yada, M., Matsumoto, M., Ishida, N. & Nakayama, K. I. U box proteins as a new family of ubiquitin-protein ligases. J. Biol. Chem. 276, 33111\u201333120 (2001).","journal-title":"J. Biol. Chem."},{"key":"3444_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nsb906","volume":"10","author":"MD Ohi","year":"2003","unstructured":"Ohi, M. D., Vander Kooi, C. W., Rosenberg, J. A., Chazin, W. J. & Gould, K. L. Structural insights into the U-box, a domain associated with multi-ubiquitination. Nat. Struct. Biol. 10, 250\u2013255 (2003).","journal-title":"Nat. Struct. Biol."},{"key":"3444_CR22","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1021\/bi051787e","volume":"45","author":"CW Vander Kooi","year":"2006","unstructured":"Vander Kooi, C. W. et al. The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases. Biochemistry 45, 121\u2013130 (2006).","journal-title":"Biochemistry"},{"key":"3444_CR23","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/ng.3568","volume":"48","author":"J Zheng","year":"2016","unstructured":"Zheng, J. et al. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Nat. Genet. 48, 747\u2013757 (2016).","journal-title":"Nat. Genet."},{"key":"3444_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1101\/gad.1925010","volume":"24","author":"EJ Song","year":"2010","unstructured":"Song, E. J. et al. The Prp19 complex and the Usp4Sart3 deubiquitinating enzyme control reversible ubiquitination at the spliceosome. Genes Dev. 24, 1434\u20131447 (2010).","journal-title":"Genes Dev."},{"key":"3444_CR25","first-page":"4866","volume":"45","author":"T Das","year":"2017","unstructured":"Das, T. et al. USP15 regulates dynamic protein-protein interactions of the spliceosome through deubiquitination of PRP31. Nucleic Acids Res. 45, 4866\u20134880 (2017).","journal-title":"Nucleic Acids Res."},{"key":"3444_CR26","doi-asserted-by":"publisher","first-page":"7498","DOI":"10.1074\/jbc.M510881200","volume":"281","author":"Y Urano","year":"2006","unstructured":"Urano, Y. et al. Involvement of the mouse Prp19 gene in neuronal\/astroglial cell fate decisions. J. Biol. Chem. 281, 7498\u20137514 (2006).","journal-title":"J. Biol. Chem."},{"key":"3444_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2013.06.007","volume":"1524","author":"T Yamada","year":"2013","unstructured":"Yamada, T. et al. The U-box-type ubiquitin ligase PRP19beta regulates astrocyte differentiation via ubiquitination of PTP1B. Brain Res. 1524, 12\u201325 (2013).","journal-title":"Brain Res."},{"key":"3444_CR28","doi-asserted-by":"publisher","first-page":"573991","DOI":"10.3389\/fbioe.2020.573991","volume":"8","author":"W Pei","year":"2020","unstructured":"Pei, W. et al. Isolation and identification of a novel anti-protein aggregation activity of lignin-carbohydrate complex from Chionanthus retusus leaves. Front Bioeng. Biotechnol. 8, 573991 (2020).","journal-title":"Front Bioeng. Biotechnol."},{"key":"3444_CR29","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1093\/hmg\/ddr049","volume":"20","author":"WM Chan","year":"2011","unstructured":"Chan, W. M. et al. Expanded polyglutamine domain possesses nuclear export activity which modulates subcellular localization and toxicity of polyQ disease protein via exportin-1. Hum. Mol. Genet. 20, 1738\u20131750 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"3444_CR30","doi-asserted-by":"publisher","first-page":"13428","DOI":"10.1073\/pnas.1204089109","volume":"109","author":"H Tsoi","year":"2012","unstructured":"Tsoi, H., Lau, T. C., Tsang, S. Y., Lau, K. F. & Chan, H. Y. CAG expansion induces nucleolar stress in polyglutamine diseases. Proc. Natl Acad. Sci. Usa. 109, 13428\u201313433 (2012).","journal-title":"Proc. Natl Acad. Sci. Usa."},{"key":"3444_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/BJ20112175","volume":"443","author":"WN Chow","year":"2012","unstructured":"Chow, W. N., Luk, H. W., Chan, H. Y. & Lau, K. F. Degradation of mutant huntingtin via the ubiquitin\/proteasome system is modulated by FE65. Biochem J. 443, 681\u2013689 (2012).","journal-title":"Biochem J."},{"key":"3444_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1091\/mbc.e13-10-0586","volume":"25","author":"Y Ding","year":"2014","unstructured":"Ding, Y. et al. Exo70E2 is essential for exocyst subunit recruitment and EXPO formation in both plants and animals. Mol. Biol. Cell. 25, 412\u2013426 (2014).","journal-title":"Mol. Biol. Cell."},{"key":"3444_CR33","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1523\/JNEUROSCI.19-23-10338.1999","volume":"19","author":"Y Chai","year":"1999","unstructured":"Chai, Y., Koppenhafer, S. L., Bonini, N. M. & Paulson, H. L. Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease. J. Neurosci. 19, 10338\u201310347 (1999).","journal-title":"J. Neurosci."},{"key":"3444_CR34","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1523\/JNEUROSCI.4474-04.2005","volume":"25","author":"KL Lim","year":"2005","unstructured":"Lim, K. L. et al. Parkin mediates nonclassical, proteasomal-independent ubiquitination of synphilin-1: implications for Lewy body formation. J. Neurosci. 25, 2002\u20132009 (2005).","journal-title":"J. Neurosci."},{"key":"3444_CR35","doi-asserted-by":"crossref","unstructured":"Chen, Z. S. et al. Planar cell polarity gene Fuz triggers apoptosis in neurodegenerative disease models. EMBO Rep. 19, e45409 (2018).","DOI":"10.15252\/embr.201745409"},{"key":"3444_CR36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1242\/dev.119.3.855","volume":"119","author":"MC Ellis","year":"1993","unstructured":"Ellis, M. C., O\u2019Neill, E. M. & Rubin, G. M. Expression of Drosophila glass protein and evidence for negative regulation of its activity in non-neuronal cells by another DNA-binding protein. Development 119, 855\u2013865 (1993).","journal-title":"Development"},{"key":"3444_CR37","doi-asserted-by":"publisher","first-page":"8071","DOI":"10.1523\/JNEUROSCI.0620-18.2018","volume":"38","author":"AC Koon","year":"2018","unstructured":"Koon, A. C. et al. Drosophila Exo70 is essential for neurite extension and survival under thermal stress. J. Neurosci. 38, 8071\u20138086 (2018).","journal-title":"J. Neurosci."},{"key":"3444_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","volume":"18","author":"JM Warrick","year":"2005","unstructured":"Warrick, J. M. et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell. 18, 37\u201348 (2005).","journal-title":"Mol. Cell."},{"key":"3444_CR39","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0092-8674(00)81200-3","volume":"93","author":"JM Warrick","year":"1998","unstructured":"Warrick, J. M. et al. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93, 939\u2013949 (1998).","journal-title":"Cell"},{"key":"3444_CR40","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1096\/fj.07-103887","volume":"22","author":"SL Wong","year":"2008","unstructured":"Wong, S. L., Chan, W. M. & Chan, H. Y. Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration. FASEB J. 22, 3348\u20133357 (2008).","journal-title":"FASEB J."},{"key":"3444_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.omtn.2019.02.015","volume":"16","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. A peptidylic inhibitor for neutralizing r(GGGGCC)exp-associated neurodegeneration in C9ALS-FTD. Mol. Ther. Nucleic Acids 16, 172\u2013185 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3444_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-11839-0","volume":"7","author":"YL Wu","year":"2017","unstructured":"Wu, Y. L. et al. Treatment with caffeic acid and resveratrol alleviates oxidative stress induced neurotoxicity in cell and Drosophila models of spinocerebellar ataxia type 3. Sci. Rep. 7, 11641 (2017).","journal-title":"Sci. Rep."},{"key":"3444_CR43","doi-asserted-by":"crossref","unstructured":"Schilling, J. et al. Deregulated splicing is a major mechanism of RNA-induced toxicity in Huntington\u2019s disease. J. Mol. Biol. 431, 1869\u20131877 (2019).","DOI":"10.1016\/j.jmb.2019.01.034"},{"key":"3444_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/BJ20110183","volume":"438","author":"H Dellago","year":"2011","unstructured":"Dellago, H. et al. Exo70, a subunit of the exocyst complex, interacts with SNEV(hPrp19\/hPso4) and is involved in pre-mRNA splicing. Biochem J. 438, 81\u201391 (2011).","journal-title":"Biochem J."},{"key":"3444_CR45","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1074\/jbc.RA118.006307","volume":"294","author":"H Hong","year":"2019","unstructured":"Hong, H. et al. AQAMAN, a bisamidine-based inhibitor of toxic protein inclusions in neurons, ameliorates cytotoxicity in polyglutamine disease models. J. Biol. Chem. 294, 2757\u20132770 (2019).","journal-title":"J. Biol. Chem."},{"key":"3444_CR46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/21541248.2017.1328998","volume":"10","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Wu, B. & Guo, W. The role of Exo70 in exocytosis and beyond. Small GTPases. 10, 331\u2013335 (2019).","journal-title":"Small GTPases."},{"key":"3444_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.mito.2010.09.001","volume":"11","author":"A Sugiura","year":"2011","unstructured":"Sugiura, A. et al. A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein. Mitochondrion 11, 139\u2013146 (2011).","journal-title":"Mitochondrion"},{"key":"3444_CR48","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1093\/hmg\/ddp380","volume":"18","author":"Z Ying","year":"2009","unstructured":"Ying, Z. et al. Gp78, an ER associated E3, promotes SOD1 and ataxin-3 degradation. Hum. Mol. Genet. 18, 4268\u20134281 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"3444_CR49","doi-asserted-by":"publisher","first-page":"11635","DOI":"10.1074\/jbc.M412042200","volume":"280","author":"NR Jana","year":"2005","unstructured":"Jana, N. R. et al. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J. Biol. Chem. 280, 11635\u201311640 (2005).","journal-title":"J. Biol. Chem."},{"key":"3444_CR50","doi-asserted-by":"publisher","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","volume":"288","author":"WL Tsou","year":"2013","unstructured":"Tsou, W. L. et al. Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo. J. Biol. Chem. 288, 34460\u201334469 (2013).","journal-title":"J. Biol. Chem."},{"key":"3444_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/srep05077","volume":"4","author":"D Chhangani","year":"2014","unstructured":"Chhangani, D., Upadhyay, A., Amanullah, A., Joshi, V. & Mishra, A. Ubiquitin ligase ITCH recruitment suppresses the aggregation and cellular toxicity of cytoplasmic misfolded proteins. Sci. Rep. 4, 5077 (2014).","journal-title":"Sci. Rep."},{"key":"3444_CR52","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1093\/nar\/gki986","volume":"33","author":"J Grillari","year":"2005","unstructured":"Grillari, J. et al. SNEV is an evolutionarily conserved splicing factor whose oligomerization is necessary for spliceosome assembly. Nucleic Acids Res. 33, 6868\u20136883 (2005).","journal-title":"Nucleic Acids Res."},{"key":"3444_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052627","volume":"7","author":"M Hertzog","year":"2012","unstructured":"Hertzog, M., Monteiro, P., Le Dez, G. & Chavrier, P. Exo70 subunit of the exocyst complex is involved in adhesion-dependent trafficking of caveolin-1. PLoS ONE 7, e52627 (2012).","journal-title":"PLoS ONE"},{"key":"3444_CR54","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.devcel.2013.07.007","volume":"26","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Exo70 generates membrane curvature for morphogenesis and cell migration. Dev. Cell. 26, 266\u2013278 (2013).","journal-title":"Dev. Cell."},{"key":"3444_CR55","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/ncb1505","volume":"8","author":"X Zuo","year":"2006","unstructured":"Zuo, X. et al. Exo70 interacts with the Arp2\/3 complex and regulates cell migration. Nat. Cell Biol. 8, 1383\u20131388 (2006).","journal-title":"Nat. Cell Biol."},{"key":"3444_CR56","doi-asserted-by":"publisher","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","volume":"27","author":"U Bichelmeier","year":"2007","unstructured":"Bichelmeier, U. et al. Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci. 27, 7418\u20137428 (2007).","journal-title":"J. Neurosci."},{"key":"3444_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-2-21","volume":"2","author":"LS Havel","year":"2009","unstructured":"Havel, L. S., Li, S. & Li, X. J. Nuclear accumulation of polyglutamine disease proteins and neuropathology. Mol. Brain 2, 21 (2009).","journal-title":"Mol. Brain"},{"key":"3444_CR58","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2013.06.003","volume":"154","author":"SH Park","year":"2013","unstructured":"Park, S. H. et al. PolyQ proteins interfere with nuclear degradation of cytosolic proteins by sequestering the Sis1p chaperone. Cell 154, 134\u2013145 (2013).","journal-title":"Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03444-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03444-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T01:05:51Z","timestamp":1674954351000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-021-03444-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,2]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["3444"],"URL":"https:\/\/doi.org\/10.1038\/s41419-021-03444-x","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,2]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Biological and chemical safety approval (14122815) from the Chinese University of Hong Kong was obtained for this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"This work was supported by the General Research Fund (14122815) and Area of Excellence Scheme (AoE\/M-05\/12) of The Research Grants Council of Hong Kong, CUHK Gerald Choa Neuroscience Centre Grant 7105306 (to H.Y.E.C.), and a Postdoctoral Fellowship in Clinical Neurosciences program between The Chinese University of Hong Kong and University of Oxford (Nuffield Department of Clinical Neurosciences and Pembroke College) supported by the Lee Hysan Foundation (to Z.S.C.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding statement"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"136"}}